The incubator, named “Dysruption,” will prototype, evaluate and implement new technology to improve mental healthcare access. It aims to connect scientists, academics, entrepreneurs and healthcare professionals with each other to discover ways to improve the patient experience.
“Our board chooses a limited number of projects to focus on at any given time and relentlessly pursues discovery and execution,” Paulette Garside, IBH’s director of product development, said in a news release. “Some projects are geared towards providers, some focus on the employer or employee, but all projects are aimed at ultimately improving care and the patient experience.”
Dysruption receives proposals for new projects year-round, which are evaluated by clinical promise, impact magnitude, and feasibility for rapid development and testing.
More articles on digital transformation:
Optum leads $26M funding round for digital therapeutics startup
Texas Children’s is building a ‘startup culture’ with innovation, tech at the forefront
Apple Watch to release new gait quality metrics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
